Solstice Health

What Solstice Health does

Solstice Health is a New York-based AI-native marketing platform purpose-built for pharmaceutical and life sciences commercial teams. Its core product, the Solstice platform, pairs proprietary generative AI models with in-house medical experts to produce promotional content for HCP, patient, market access, medical affairs, and commercial strategy audiences across therapeutic areas including oncology, rare disease, immunology, cardiology, neurology, and respiratory. The platform compresses traditional pharma marketing asset delivery cycles from approximately three months to ten days and reduces MLR review cycles from 3.2 to 1.2 rounds per asset by automating fact-checking, regulatory evaluation, and submission workflows.

The technology stack is structured around three core modules: the Regulatory Assistant (six autonomous AI agents evaluating content against FDA 21 CFR Part 202.1.7 requirements and custom brand rules, with continuous regulatory-update monitoring), the Fact Check Assistant (RAG-style validation against clinical papers, brand labels, and internal trial results), and the Solstice Fair Balance (SFB) Score (computer-vision-driven quantification of risk vs. benefit prominence using a ±15% threshold derived from 1,000+ promotional documents). The platform integrates natively with Veeva PromoMats to automate MLR submission and pull review comments back into the Solstice dashboard.

Solstice monetizes through a hybrid model combining AI-native agency engagements (engagement teams operating the platform on behalf of clients) and SaaS-style platform subscriptions, particularly for small and mid-size pharma teams replacing traditional agency-of-record (AOR) contracts. Pricing is custom and quote-based. The company serves 12+ pharmaceutical organizations including multiple top-20 global pharma brands, has raised approximately $25 million across a February 2024 seed round and a May 2026 Series A led by Transformation Capital, and is led by co-founders Yiwen Li and Aris Saxena.

Name

Solstice Health

Legal name

Solstice Health

Website

https://solsticehealth.co

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Solstice Health is an AI-native pharma marketing platform that pairs generative AI with in-house medical experts to compress compliant promotional content cycles from months to ~10 days, serving 12+ pharmaceutical companies including top-20 global pharma brands across HCP, patient, and market access audiences.

Ownership category

akta.pro rank

Product category

Pharmaceutical Marketing Software

NAICS

Software Publishers (513210), Advertising Agencies (541810)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Marketing Automation & Lifecycle/Drip Campaign Management (MPAAAIAC)

Keywords

• Pharmaceutical marketing platform
• AI life sciences marketing
• MLR compliance automation
• Pharma content generation
• Regulatory review automation

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. AI-native marketing agency engagements: Solstice positions itself as an AI-native agency with engagement teams that operate its platform on behalf of pharma clients, suggesting managed-services / agency-fee revenue layered on top of the underlying platform.
2. Platform subscription / SaaS: Platform capabilities (brand library, content generation, MLR submission, analytics) imply a recurring SaaS component, particularly for small/mid-size pharma teams that use Solstice to replace AOR contracts.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

Solstice Health is an AI-native pharmaceutical marketing platform that pairs generative AI with in-house medical experts to produce compliant marketing content for pharma and life sciences brands. The platform compresses traditional pharma marketing asset delivery cycles from approximately three months to about 10 days, automates medical-legal-regulatory (MLR) review through agentic AI, and submits approved assets directly into Veeva PromoMats. Customers engage Solstice through a hybrid SaaS-plus-engagement-team model that replaces traditional agency-of-record (AOR) contracts.

Product overview

Solstice is a single unified AI-native pharmaceutical marketing platform that combines the core Solstice platform with several integrated sub-products and modules designed to accelerate pharmaceutical commercialization. The core Solstice platform serves as the foundation, working alongside the Regulatory Assistant (which uses an agentic AI approach to evaluate content against FDA 21 CFR requirements), the Fact Check Assistant (which validates claims against clinical knowledge bases of clinical papers, brand labels, and internal trial results), and the Solstice Fair Balance Score or SFB Score (which quantifies visual and textual risk and benefit information for fair balance compliance). Together, these products compress pharmaceutical marketing asset delivery cycles from three months to roughly 10 days by pairing generative AI algorithms with in-house medical experts, while integrating with Veeva PromoMats for automated MLR submission.

Differentiator

Problem solved

Functional benefit

Products and services

• Solstice AI Platform
• AI-Native Marketing Agency Engagements

Quantifiable outcome

• 12x faster campaign launches vs. traditional agencies
• +6 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability10 records

Feature5 records

Partnerships

Two partnerships are on record, tiered flagship and minor.

• Veeva (PromoMats)flagshipTechnology or IntegrationSolstice integrates with Veeva PromoMats, automatically submitting approved marketing content into clients' MLR/regulatory review workflows and pulling review comments back into the Solstice dashboard.
• CoforgeminorStrategic or Co-development PartnerAnnounced Agentic AI deal with Solstice (April 2026), driving a 6.47% share price increase for Coforge; partnership centers on Agentic AI in insurance.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Veeva Systems: Veeva owns PromoMats, the dominant pharma digital asset management and MLR workflow that Solstice integrates into. Veeva is both a critical distribution partner and the most credible broad incumbent capable of bundling AI-native MLR automation natively.
• IQVIA: IQVIA is a global life sciences services and technology giant offering commercial outsourcing, real-world data, and marketing technology. Its commercial/marketing tech portfolio overlaps with Solstice's AI-native pharma content and HCP/patient engagement stack.
• Ogilvy Health: Ogilvy Health is a large global healthcare advertising and marketing agency competing for the same pharma AOR contracts Solstice targets. As pharma buyers push for AI-driven, agency-displacing models, Ogilvy is the legacy incumbent under most pressure.
• Accenture Song (Life Sciences): Accenture Song is the digital creative and marketing services arm of Accenture with a dedicated life sciences practice serving pharma AOR and content operations needs, directly contesting Solstice's enterprise pharma accounts.

Direct peers

• Indegene: Indegene is a commercial/marketing services and technology provider purpose-built for life sciences, offering MLR review, content operations, and AI-driven omnichannel marketing for pharma — directly overlapping with Solstice's pharma marketing + MLR automation thesis.
• EVERSANA: EVERSANA is a pharma commercialization services and technology platform covering content, MLR, and field enablement. Its MLR/commercial-content workflows directly compete with Solstice's automated medical-legal-regulatory review and content generation offerings.
• Real Chemistry: Real Chemistry is a healthcare-focused marketing agency and data platform serving pharma and biotech with brand strategy, content, and AI-enabled engagement — a direct competitor to Solstice's AI-native agency positioning across HCP and patient marketing.

Emerging players

• DeepIntent: DeepIntent is a healthcare advertising and marketing technology platform combining data, AI, and HCP/patient activation. It is comparable to Solstice on the AI-enabled pharma marketing and audience activation axis.
• Doceree: Doceree is an AI-driven HCP marketing platform offering programmatic messaging, content, and analytics for pharma. It overlaps with Solstice on the HCP marketing and content enablement side, though with a narrower channel focus.

Others

• H1 (now part of Definitive Healthcare): H1 / Definitive Healthcare provides healthcare professional, clinical, and commercial data used by pharma marketing teams. It is an enabling data layer adjacent to Solstice's content and audience-segmentation workflows rather than a direct competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/solsticehealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Solstice Health